Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | -2.16% | 152.84 | 0.7% | $1192.90m | |
PFE | Pfizer Inc. | -0.96% | 34.06 | 0.9% | $1173.78m | |
MRK | Merck & Co., Inc. | -1.52% | 72.19 | 0.7% | $851.36m | |
BMY | Bristol-Myers Squibb Co. | -2.61% | 59.17 | 1.0% | $791.01m | |
ABBV | AbbVie, Inc. | -1.06% | 105.58 | 1.9% | $738.20m | |
LLY | Eli Lilly & Co. | -0.81% | 200.36 | 1.1% | $642.04m | |
AZN | AstraZeneca Plc | -0.56% | 46.90 | 1.2% | $494.43m | |
GSK | GlaxoSmithKline Plc | -0.39% | 34.11 | 0.2% | $282.58m | |
NVS | Novartis AG | -1.18% | 83.19 | 0.2% | $165.16m | |
SNY | Sanofi | 0.51% | 45.69 | 0.2% | $156.93m | |
VTRS | Viatris, Inc. | -3.17% | 13.44 | 0.0% | $147.01m | |
VERU | Veru, Inc. | -8.75% | 12.00 | 0.0% | $99.82m | |
NVO | Novo Nordisk A/S | -3.40% | 69.03 | 0.1% | $84.24m | |
KALV | KalVista Pharmaceuticals, Inc. | -1.31% | 31.77 | 0.4% | $82.65m | |
RPRX | Royalty Pharma Plc | -3.19% | 42.18 | 0.2% | $80.23m |
Company Profile
Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.